Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5526_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
29 Мб
Скачать
43 Headache Attributed toHypothyroidism
16. Vincent MB.Fisiopatologia da enxaqueca. Arq Neuropsiquiatr. 1998;56:841–51.
17. Aloisi AM, Vodo S, Buonocore M.Pain and thyroid hormones. Neurol Sci. 2013;34:1501–8.
18. Bauer M, Whybrow PC.Thyroid hormone, neural tissue and mood modulation. World J Biol Psychiatry. 2001;2:59–69.
19. Hassan WA, Aly MS, Rahman TA, Shahat AS.Impact of experimental hypothyroidism on monoamines level in discrete brain regions and other peripheral tissues of young and adult male rats. Int J Dev Neurosci. 2013;31(4):225–33. https://doi.org/10.1016/j.ijdevneu.2013.02.001.
20. Stipcevic T, Kusacic-Kuna S, Dezeljin M, Dodig D, Korsic M, Pivac N, Muck-Seler D.Platelet serotonin concentration and monoamine oxidase activity in hypothyroid patients. Horm Res. 2009;71(4):207–12. https://doi.org/10.1159/000201109. Epub 2009 Mar 4.
21. Bortolotto VC, Pinheiro FC, Araujo SM, Poetini MR, Bertolazi BS, de Paula MT, Meichtry LB, de Almeida FP, de Freitas CS, Jesse CR, Prigol M.Chrysin reverses the depressive-like behavior induced by hypothyroidism in female mice by regulating hippocampal serotonin and dopamine. Eur J Pharmacol. 2018;822:78–84. https://doi.org/10.1016/j.ejphar.2018.01.017.
22. Ito JM, Valcana T, Timiras PS. Effect of hypo- and hyperthyroidism on regional mono­amine metabolism in the adult rat brain. Neuroendocrinology. 1977;24(1):55–64. https://doi.
org/10.1159/000122696.
23. Tousson E, Ibrahim W, Arafa N, Akela M. Monoamine concentrations changes in the PTU­induced hypothyroid rat brain and the ameliorating role of folic acid. Hum Exp Toxicol. 2011;31(3):282–9. https://doi.org/10.1177/0960327111405863.
24. Zhang Q, Feng JJ, Yang S, Liu XF, Li JC, Zhao H.Lateral habenula as a link between thyroid and serotoninergic system modiates depressive symptoms in hypothyroidism rats. Brain Res Bull. 2016;124:198–205.
25. Sandrini M, Vitale G, Vergoni AV, Ottani A, Bertolini A.Effect of acute and chronic treatment with triiodothyronine on serotonin levels and serotonergic receptor subtypes in the rat brain. Life Sci. 1996;58(18):1551–9.
26. Hela D, Smith S.The effects of acute and repeated administration of T3 to mice on 5-HT1 and 5-HT2 function in the brain and its inuence on the actions of repeated electroconvulsive shock. Neuropharmacology. 1988;27(12):1239–48.
27. Yu D, Zhou H, Yang Y, Jiang Y, Wang T, Lv L, Zhou Q, Yang Y, Dong X, He J, Huang X, Chen J, Wu K, Xu L, Mao R. The bidirectional effects of hypothyroidism and hyperthyroidism on anxiety- and depression-like behaviors in rats. Horm Behav. 2015;69:106–15. https://doi.
org/10.1016/j.yhbeh.2015.01.003.
28. Cleare AJ, McGregor A, Chambers SM, Dawling S, O’Keane V. Thyroxine replacement increases central 5-hydroxytryptamine activity and reduces depressive symptoms in hypothy­roidism. Neuroendocrinology. 1996;64(1):65–9. https://doi.org/10.1159/000127099.
29. Kulikov A, Moreau X, Jeanningros R.Effects of experimental hypothyroidism on 5-HT1A, 5-HT2A receptors, 5-HT uptake sites and tryptophan hydroxylase activity in mature rat brain1. Neuroendocrinology. 1999;69(6):453–9. https://doi.org/10.1159/000054449.
30. Jin Z, Ling J, Yu J, He M, Ni P, Zhang F, Wang Y.Serotonin 2A receptor function and depression­like behavior in rats model of hypothyroidism. Exp Brain Res. 2021;239(8):2435–44. https://
doi.org/10.1007/s00221- 021- 06129- 1.
31. Kulikov AV, Jeanningro R. Vliianie gipertireoidizma na 5-HT1A-, 5-HT2A-retseptory i belok-transporter serotonina v golovnom mozgu krys [Effect of hypothyroidism on 5-HT1A-, 5-HT2A-receptors and serotonin transporter in the rat brain]. Rossiiskii ziologicheskii zhur­nal imeni IM Sechenova. 2000;86(3):312–9.
32. Huang J, Fan Y, Jia Y, Hong Y. Antagonism of 5-HT(2A) receptors inhibits the expression of pronociceptive mediator and enhances endogenous opioid mechanism in carrageenan­induced inammation in rats. Eur J Pharmacol. 2011;654(1):33–41. https://doi.org/10.1016/j.
ejphar.2010.12.007.
33. Wang D, Gao Y, Ji H, Hong Y.Topical and systemic administrations of ketanserin attenuate hypersensitivity and expression of CGRP in rats with spinal nerve ligation. Eur J Pharmacol. 2010;627(1–3):124–30. https://doi.org/10.1016/j.ejphar.2009.11.011.
https://doi.org/10.1016/0024- 3205(96)00129- 4.
https://doi.org/10.1016/0028- 3908(88)90026- 3.
415
416
34. Okamoto K, Imbe H, Morikawa Y, Itoh M, Sekimoto M, Nemoto K, Senba E. 5-HT2A receptor subtype in the peripheral branch of sensory bers is involved in the potentiation of inamma­tory pain in rats. Pain. 2002;99(1–2):133–43.
35. Wang D, Chen T, Gao Y, Quirion R, Hong Y.Inhibition of SNL-induced upregulation of CGRP and NPY in the spinal cord and dorsal root ganglia by the 5-HT(2A) receptor antagonist ket­anserin in rats. Pharmacol Biochem Behav. 2012;101(3):379–86. https://doi.org/10.1016/j.
pbb.2012.02.004.
36. van Hoogstraten WS, MaassenVanDenBrink A.The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse. J Headache Pain. 2019;20(1):54.
https://doi.org/10.1186/s10194- 019- 1007- y.
37. Bruno AN, Pochmann D, Ricachenevsky FK, Fontella FU, Bonan CD, Dalmaz C, Barreto­Chaves ML, Sarkis JJ.Nociceptive response and adenine nucleotide hydrolysis in synapto­somes isolated from spinal cord of hypothyroid rats. Neurochem Res. 2005;30(9):1155–61.
https://doi.org/10.1007/s11064- 005- 7867- 3.
38. Tepper DE, Tepper SJ, Sheftell FD, Bigal ME.Headache attributed to hypothyroidism. Curr Pain Headache Rep. 2007;11(4):304–9.
39. Gifn NJ, Kowacs F, Libri V, Williams P, Goadsby PJ, Kaube H.Effect of the adenosine A1 receptor agonist GR79236 on trigeminal nociception with blink reex recordings in healthy human subjects. Cephalalgia. 2003;23(4):287–92.
00511.x.
40. Khawaja NM, Taher BM, Barham ME, Naser AA, Hadidy AM, Ahmad AT, Hamamy HA, Yaghi NA, Ajlouni KM. Pituitary enlargement in patients with primary hypothyroidism. Endocr Pract. 2006;12(1):29–34. https://doi.org/10.4158/EP.12.1.29.
41. Arafah BM, Prunty D, Ybarra J, Hlavin ML, Selman WR.The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab. 2000;85(5):1789–93. https://doi.
org/10.1210/jcem.85.5.6611.
42. Levy MJ, Jäger HR, Powell M, Matharu MS, Meeran K, Goadsby PJ.Pituitary volume and headache: size is not everything. Arch Neurol. 2004;61(5):721–5. https://doi.org/10.1001/
archneur.61.5.721.
43. Tasnim S, Wilson SG, Walsh JP, Nyholt DR.Cross-trait genetic analyses indicate pleiotropy and complex causal relationships between headache and thyroid function traits. Genes (Basel). 2022;14(1):16. Published 2022 Dec 21. https://doi.org/10.3390/genes14010016.
44. Tasnim S, Wilson SG, Walsh JP, Nyholt DR. Shared genetics and causal relation­ships between migraine and thyroid function traits. Cephalalgia. 2023;43(2) https://doi.
org/10.1177/03331024221139253.
45. Tasnim S, Nyholt DR.Migraine and thyroid dysfunction: co-occurrence, shared genes and biological mechanisms. Eur J Neurol. 2003;30(6):1815–27.
46. Evans RW, Timm JS.New daily persistent headache caused by a multinodular goiter and head­aches associated with thyroid disease. Headache. 2017;57(2):285–9.
47. Topliss DJ, White EL, Stockigt JR.Signicance of thyrotropin excess in untreated primary adrenal insufciency. J Clin Endocrinol Metab. 1980;50(1):52–6. https://doi.org/10.1210/
jcem- 50- 1- 52.
48. Wilson SA, Stem LA, Bruehlman RD.Hypothyroidism: diagnosis and treatment. Am Fam Physician. 2021;103(10):605–13.
49. Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RP, Rosenthal MS, Sawka AM, American Thyroid Association Task Force on Thyroid Hormone Replacement. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670–751. https://doi.org/10.1089/thy.2014.0028. PMID: 25266247; PMCID: PMC4267409.
https://doi.org/10.1016/s0304- 3959(02)00070- 2.
https://doi.org/10.1007/s11916- 007- 0208- 2.
https://doi.org/10.1046/j.1468- 2982.2003.
P. G. Ferreira et al.
Chapter 44
Cardiac Cephalalgia
Viníciusda SilvaLessadeOliveira , VictorAlfonsoGarciaOrtiz , andVaniseGrassi

44.1 Introduction

The term “cardiac headache” was initially introduced by Lipton etal. in 1997, fol­lowing the report of two cases of exertional headache. Their study detailed two male patients, aged 57 and 67, who experienced headache developing 5–15minutes after the onset of vigorous exercise, with improvement occurring minutes or hours after cessation of the activity [1]. A subsequent literature review identied similar case reports, demonstrating that symptoms either decreased or resolved completely with pharmacological and/or surgical interventions aimed at correcting myocardial isch­emia [2].
Since it is a rare condition among headaches, the literature primarily consists of case reports, making it challenging to establish robust diagnostic criteria [3]. This is partly due to its atypical presentation, with an absence of specic neurological signs and variability in pain characteristics, which may mimic primary headaches [4]. Additionally, cardiac headache can be an isolated manifestation of myocardial
V. da SilvaLessadeOliveira Postgraduate Program in Medicine, Pediatrics, and Child Health, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil
V. A. G. Ortiz Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil
V. Grassi ( Department of Neurology, Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil
Switzerland AG 2026 D. Uludüz et al. (eds.), Rare Causes of Headache Disorders, Headache,
https://doi.org/10.1007/978-3-032-10242-3_44
*)
417© The Author(s), under exclusive license to Springer Nature
418
V. da SilvaLessadeOliveira et al.
ischemia, frequently underdiagnosed due to low awareness and its unconventional presentation. Unlike typical angina, which is characterized by oppressive chest pain radiating to the arm and jaw, cardiac headache can occur in isolation, triggered by physical exertion [5]. Therefore, a detailed clinical approach—based on medical history, cardiovascular risk factor assessment, and complementary exams such as stress tests and coronary angiography—is essential for differential diagnosis and appropriate treatment of these patients [2, 3, 610].

44.2 Pathophysiology

While the precise pathophysiology of cardiac cephalalgia remains incompletely understood, several key hypotheses are gaining increasing acceptance. First, referred pain is the most widely cited mechanism, supported by numerous arti­cles and case reports. This theory posits that the association between headache and chest pain arises from the somatic nervous system via its visceral afferent and efferent bers. Cardiac stimuli are detected by cardiac nociceptors and ascend through afferent pathways, including the spinothalamic and spinoreticu­lar tracts, ultimately reaching the sensory cortex and manifesting as a headache [2, 5, 11]. The parasympathetic autonomic nervous system also plays a role, with vagal nerve (cranial nerve X) afferent bers terminating in the nucleus of the solitary tract. These bers connect with spinothalamic tract neurons, further con­tributing to cortical activation and headache generation [3]. Notably, some ascending neurons synapse at the C1–C2 levels, connecting with the trigeminal nerve (cranial nerve V) nucleus, which explains the potential for shoulder and jaw pain in these patients [5, 12].
Second, transient intracranial hypertension is proposed as another mechanism [13]. Following acute myocardial ischemia, reduced cardiac output diminishes the heart’s pumping capacity, impacting systemic venous return, including cerebral venous drainage. This disruption alters cerebral blood ow, leading to increased cerebral perfusion pressure and, consequently, intracranial pressure [13].
The third and last hypothesis suggests that inammatory mediators are impli­cated in cardiac cephalalgia. Acute myocardial injury triggers the release of pro­inammatory substances from the cardiac muscle, such as bradykinin, serotonin, substance P, histamine, and adenosine. These mediators can induce cerebral edema, cerebral artery vasodilation, and cerebral cortical hypoperfusion, ultimately mani­festing as a headache [2, 5].
44 Cardiac Cephalalgia
419

44.3 Case Presentation

A 61-year-old male with a history of hypertension, managed with regular antihyper­tensive therapy, and obesity presented to the emergency department with acute pre­cordial pain. The pain began approximately 30minutes prior while the patient was at rest at home. He described the pain as oppressive, retrosternal, and radiating to the left shoulder and upper limb, accompanied by dyspnea, nausea, and a single episode of emesis. Concurrently, the patient experienced a severe, acute-onset head­ache localized to the vertex, characterized as oppressive and increasing in intensity with the worsening chest pain. Upon arrival, vital signs revealed a blood pressure of 145/80 mmHg; other vital signs were unremarkable. Neurological examination revealed no focal decits or abnormalities. An electrocardiogram (ECG) demon­strated ST-segment elevation greater than 1.5mm in leads II, III, and aVF.An ultra­sensitive troponin level was elevated at 1500 ng/L. Laboratory investigations showed inammatory markers within normal limits and no evidence of autoimmune or infectious etiologies. A computed tomography (CT) scan of the head revealed normal anatomical ndings, without evidence of hemorrhage, mass lesions, or other abnormalities. The patient was transferred to the cardiac catheterization laboratory, where primary percutaneous coronary intervention (PCI) revealed a 90% occlusion of the right coronary artery. Following PCI, the patient reported signicant improve­ment in both chest pain and headache.

44.4 Case Discussion

The rarity of cardiac cephalalgia makes its diagnosis complex, given its varied clini­cal presentation [3]. The literature suggests a patient prole typically over 50years old male exhibiting established cardiovascular risk factors including systemic arte­rial hypertension, dyslipidemia, obesity, and a smoking history [1419]. However, this is not absolute, as cases have been reported in younger individuals and in patients without cardiovascular risk factors [13, 20, 21].
Cardiac headache is frequently described as diffuse or localized to the vertex and can be either unilateral or bilateral. Its presentation is characterized by a rapid­onset, intense, and oppressive headache, sometimes described as a sensation that the head is about to explode [4, 10, 15, 18, 19, 22, 23]. Patients generally deny photo­phobia and phonophobia [11, 19, 24, 25]. Nausea and signs and symptoms of myo­cardial ischemia, such as retrosternal, epigastric, or left upper limb pain, may accompany the headache [4, 18, 24, 26]. Cardiac headache is usually triggered by physical exertion, including activities such as sexual activity or walking, and gener­ally improves soon after stopping the activity [1, 8, 27].
420
V. da SilvaLessadeOliveira et al.
Although age is a relevant factor in the anamnesis, other characteristics must be carefully assessed for proper patient identication. Gathering information about headache presentation, similarity to previous typical headache episodes, and response to commonly used headache medications is crucial [28]. Additionally, investigating the presence of comorbidities, as previously mentioned, should be part of the patient’s evaluation.
The assessment of these patients involves stress testing, which usually reveals recurrent headaches associated with ST-segment depression, and coronary angiog­raphy [2, 3, 710]. A review, involving 30 patients, reinforced the importance of performing brain magnetic resonance imaging (MRI) to exclude other underlying pathological conditions [6]. Regarding treatment, the triptans, as selective 5-HT
1B-1D
receptor agonists, promote vasoconstriction of extracerebral and intracranial arter­ies in migraine treatment, but they also exert a mild vasoconstrictive effect on coro­nary arteries [6]. This justies why triptans are contraindicated for patients with cardiovascular disease, whereas improvement is seen with nitrate administration or surgical intervention (bypass, myocardial revascularization, percutaneous translu­minal coronary angioplasty, stenting) [1, 6, 8, 22, 23]. Furthermore, the literature has emphasized that the immediate relief achieved with nitrate administration is a consistent characteristic linking headaches to myocardial ischemia [7]. The adverse reaction to triptan administration may aid in the identication of cardiac head­ache [13].
44.5 Headache Characteristics ofCardiac Cephalalgia
A summary of headache characteristics and associated symptoms from the literature is presented in Table44.1.
44 Cardiac Cephalalgia
Multivessel
bypass surgery
C (1;
ICHD-3
Associated
signs and
2a,b)
criteria Intervention
Pain radiating
to the shoulders
symptoms
Antianginal
C (1;
Two-stage
therapy
C (1;
2a,b)
symptoms
denied
revascularization
with drug-eluting
stents;
individualized
therapy with dual
2a,b;
3c,d)
symptoms
denied
antiplatelet
therapy combined
with anticoagulant
therapy
Coronary
angioplasty
2a,b;
3a,c,d)
Stent
C (1;
2a,b;
3a,b)
diaphoresis,
nausea
421
(continued)
Triggering
or
aggravating
Headache
Onset
Sex
factors Relief factors
location Character Intensity
Occipital Exertion Rest;
mode
Female
(Age)
Rest Associated
sublingual
nitroglycerine
Exertion
Bilateral
Male
(56–60)
Rest Associated
cycling)
Oppressive Moderate Mild
Vertex;
Female
exertion
bilateral
(74)
(running or
temporal
(40)
frontal
Exertion Rest C (1;
on the
visual
Severe (10
hemicrania
and facial
Acute Left
Female
(68)
analogue
scale)
headache
Severe Dizziness,
Female
(81)
Wang and
Lin (2008)
Martínez
etal. (2002)
Ortiz etal.
Blacky etal.
Rambihar
(year)
(2001) [29]
Table 44.1 Case reports found in the literature review
Author
(1987) [30]
(2019) [11]
[3]
[25]
422
ICHD-3
criteria Intervention
Associated
signs and
symptoms
Myocardial
revascularization
C (1;
2a,b;
3a,c,d)
denied
associated
symptoms. In
another
episode, he
reported the
Stent
2a,b;
presence of
chest tightness
Coronary artery
bypass
C (1;
2a,b;
3c,d)
3a,d, 4)
Retrosternal
pain and
occasional
V. da SilvaLessadeOliveira et al.
Percutaneous
transluminal
coronary
angiography,
stenting of LAD,
and bifurcation of
the rst diagonal
and the RCA
C (1;
2a,b;
3a,c, d)
radiating to
upper limbs,
chest
discomfort,
palpitations,
cold sweating,
and facial
numbness of
both arms
pallor
Triggering
or
aggravating
Headache
Onset
Sex
factors Relief factors
Severe Exertion Initially, he
location Character Intensity
Acute Occipital
mode
Male
(Age)
(left)
(58)
C (1;
Non-
throbbing
parietal
Bilateral
Male
(55)
Sublingual
nitroglycerin
exertion
Bregmatic – Severe Stress and
Male
(62)
Nitrates Occasionally
cold
stimuli, and
sexual
Pulsatile Severe Exertion,
temporal
Bilateral
Male
(40)
activities
Table 44.1 (continued)
Author
(year)
Sathirapanya
Wang etal.
Lefkowitz
and Biller
Cutrer and
Huerter
(2004) [19]
(2006) [14]
(1982) [18]
(2017) [31]
44 Cardiac Cephalalgia
423
(continued)
Nitrate and
calcium channel
blockers
C (1;
2a,b)
roof of the
mouth and
down both
arms, tightness
Radiated to the
temperature
variation
Percutaneous
coronary
2a,b)
in the chest
angioplasty and
thrombus
nitroglycerin
aspiration
C (1) Sublingual
constrictive,
retrosternal
chest pain with
malaise, pallor,
reduced level of
consciousness,
and a mild
sensorimotor
decit of the
left upper and
lower limb
Frontal Exertion,
Female
(78)
Fleetcroft
and
Maddocks
C (1;
Female
(83)
Sun etal.
(1985) [12]
(2021) [13]
Severe,
Male
(40)
Latte etal.
(1996) [26]
424
ICHD-3
criteria Intervention
nitroglycerin
C (2a) Sublingual
bypass
2a,b;
3d)
Stent
B; C (1;
3a)
Coronary artery
V. da SilvaLessadeOliveira et al.
Nitroglycerin,
aspirin,
enoxaparin,
captopril, and
metoprolol
B; C (1;
3a, c, 4)
Stent, aspirin,
clopidogrel,
atorvastatin,
bisoprolol,
ramipril and
C (1;
2a,b; 3c)
lansoprazole
Associated
signs and
Triggering
or
aggravating
Headache
Onset
symptoms
discomfort and
factors Relief factors
Rest Chest
Moderate-
to- severe
occipital
location Character Intensity
Vertex;
mode
slight
diaphoresis
Exertion C (1;
Chest
discomfort
sublingual
Severe Exertion Rest or
bilateral
Acute Vertex,
as shortness of
nitroglycerin
Symptoms such
Severe (10
out of
shooting
occipital,
eyeball
Acute Sharp or
breath and
discomfort in
the chest, arm,
10in
severity)
jaw, neck, or
abdomen are
denied
in the chest
Acute Oppressive Severe Warm sensation
Table 44.1 (continued)
Sex
(Age)
Author
(year)
Male
(59)
Gutiérrez-
Morlote and
Pascual
Male
Lance and
(2002) [16]
Female,
(62)
Wei and
Lambros
(1998) [17]
Male
(36–85)
Wang (2008)
[28]
Male
(70)
Famularo
etal. (2002)
[15]
Male
(64)
Lazari etal.
(2019) [32]